Intellipharmaceutics International Inc. (IPCI)の価格はいくらですか

Intellipharmaceutics International Inc. (IPCI)の価格は$0.05897422です

Intellipharmaceutics International Inc. (IPCI)の時価総額は何ですか

Intellipharmaceutics International Inc. (IPCI)の時価総額は$1.64Mです

Intellipharmaceutics International Inc.（IPCI）PBR（株価純資産倍率）

Intellipharmaceutics International Inc., founded in Toronto, Canada, in 1998, is a pharmaceutical company that focuses on the research, development, and manufacturing of innovative and generic controlled-release and targeted-release oral solid dosage medications, primarily for the United States market. The company leverages its patented Hypermatrix technology to create advanced drug delivery systems, an array of product candidates, and a robust pipeline across diverse therapeutic areas, including neurological, cardiovascular, gastrointestinal, diabetes, and pain management conditions. Its current product portfolio includes extended-release formulations like Focalin XR for hyperactivity disorder, Keppra XR for partial onset seizures, Effexor XR to treat depression, and Protonix for gastroesophageal reflux disease. Other offerings feature Glucophage XR for type 2 diabetes, Seroquel XR for schizophrenia and mood disorders, Lamictal XR for epilepsy, Pristiq for depression, Coreg CR for heart failure and hypertension, and Ranexa for chronic angina. Furthermore, Intellipharmaceutics is actively developing additional controlled-release drugs such as OxyContin for pain relief and Regabatin XR for neuropathic pain management. The company operates under a license and commercialization agreement with Par Pharmaceutical Inc.

年	P/B比率	変化
提供された日付のデータは十分ではありません。

年

P/B比率

変化

提供された日付のデータは十分ではありません。

企業	P/B比率	P/B比率の差	国
Vertex Pharmaceuticals Incorporated VRTX.US	6.3419	-	US
Argenx SE ARGX.US	6.2413	-	NL
Lonza Group AG LONN.SW	-	-	CH
Samsung Biologics Co.,Ltd. 207940.KS	-	-	KR
UCB S.A. UCB.BR	3.4612	-	BE

企業

P/B比率

P/B比率の差

国